Tapewire

NYSE · USD

BMY

BRISTOL MYERS SQUIBB CO

Export transactions ↓
Tapewire entity
1662
SEC CIK
0000014272
Parsed reports
2,253

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202602
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 10, 2024 Filed Mar 13, 2024 00:31 UTC
Holzer Phil MSVP and Controller
GrantPerformance Shares · Derivative 7,407 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000069 · wk-form4_1710289869.xml · derivative · entry 16

Holzer Phil M · CIK 0002012588 · SVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,407

Underlying: Common Stock, $0.10 par value · 7,407 shares

Expires 2027-03-10

F13 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2027.

F13 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2027.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:31 UTC
Holzer Phil MSVP and Controller
Exercise / conversionPerformance Shares · Derivative 4,206 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000069 · wk-form4_1710289869.xml · derivative · entry 15

Holzer Phil M · CIK 0002012588 · SVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 4,206 shares

Expires 2024-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return.

F12 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:31 UTC
Holzer Phil MSVP and Controller
GrantMarket Share Units · Derivative 4,938 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000069 · wk-form4_1710289869.xml · derivative · entry 14

Holzer Phil M · CIK 0002012588 · SVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,938

Underlying: Common Stock, $0.10 par value · 4,938 shares

Expires 2028-03-10

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F10 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:31 UTC
Holzer Phil MSVP and Controller
OtherMarket Share Units · Derivative 768 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000069 · wk-form4_1710289869.xml · derivative · entry 13

Holzer Phil M · CIK 0002012588 · SVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,307

Underlying: Common Stock, $0.10 par value · 768 shares

Expires 2027-03-10

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F11 · shares: Represents the cancellation of one-quarter of market share units granted on March 10, 2023 due to the 80% minimum payout factor not being achieved.

F10 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:31 UTC
Holzer Phil MSVP and Controller
OtherMarket Share Units · Derivative 810 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000069 · wk-form4_1710289869.xml · derivative · entry 12

Holzer Phil M · CIK 0002012588 · SVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,621

Underlying: Common Stock, $0.10 par value · 810 shares

Expires 2026-03-10

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F9 · shares: Represents the cancellation of one-quarter of market share units granted on March 10, 2022 due to the 80% minimum payout factor not being achieved.

F10 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:31 UTC
Holzer Phil MSVP and Controller
Exercise / conversionMarket Share Units · Derivative 701 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000069 · wk-form4_1710289869.xml · derivative · entry 11

Holzer Phil M · CIK 0002012588 · SVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 701

Underlying: Common Stock, $0.10 par value · 701 shares

Expires 2025-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:31 UTC
Holzer Phil MSVP and Controller
Exercise / conversionMarket Share Units · Derivative 613 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000069 · wk-form4_1710289869.xml · derivative · entry 10

Holzer Phil M · CIK 0002012588 · SVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 613 shares

Expires 2024-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2020.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:31 UTC
Holzer Phil MSVP and Controller
Tax withholdingCommon Stock, $0.10 par value 992 $53.79 $53,359.68
Disclosure

SEC source: 0000014272-24-000069 · wk-form4_1710289869.xml · nonDerivative · entry 9

Holzer Phil M · CIK 0002012588 · SVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,460

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:31 UTC
Holzer Phil MSVP and Controller
OtherCommon Stock, $0.10 par value 1,464 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000069 · wk-form4_1710289869.xml · nonDerivative · entry 8

Holzer Phil M · CIK 0002012588 · SVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,452

F6 · shares: Adjustment to Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:31 UTC
Holzer Phil MSVP and Controller
Exercise / conversionCommon Stock, $0.10 par value 4,206 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000069 · wk-form4_1710289869.xml · nonDerivative · entry 7

Holzer Phil M · CIK 0002012588 · SVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,916

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: Amount represents distribution of performance shares earned under the 2021-2023 Long-Term Performance Award.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:31 UTC
Holzer Phil MSVP and Controller
Tax withholdingCommon Stock, $0.10 par value 210 $53.79 $11,295.90
Disclosure

SEC source: 0000014272-24-000069 · wk-form4_1710289869.xml · nonDerivative · entry 6

Holzer Phil M · CIK 0002012588 · SVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,710

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:31 UTC
Holzer Phil MSVP and Controller
OtherCommon Stock, $0.10 par value 121 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000069 · wk-form4_1710289869.xml · nonDerivative · entry 5

Holzer Phil M · CIK 0002012588 · SVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,920

F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:31 UTC
Holzer Phil MSVP and Controller
Exercise / conversionCommon Stock, $0.10 par value 701 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000069 · wk-form4_1710289869.xml · nonDerivative · entry 4

Holzer Phil M · CIK 0002012588 · SVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,041

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2021.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:31 UTC
Holzer Phil MSVP and Controller
Tax withholdingCommon Stock, $0.10 par value 187 $53.79 $10,058.73
Disclosure

SEC source: 0000014272-24-000069 · wk-form4_1710289869.xml · nonDerivative · entry 3

Holzer Phil M · CIK 0002012588 · SVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,340

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:31 UTC
Holzer Phil MSVP and Controller
OtherCommon Stock, $0.10 par value 97 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000069 · wk-form4_1710289869.xml · nonDerivative · entry 2

Holzer Phil M · CIK 0002012588 · SVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,527

F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:31 UTC
Holzer Phil MSVP and Controller
Exercise / conversionCommon Stock, $0.10 par value 613 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000069 · wk-form4_1710289869.xml · nonDerivative · entry 1

Holzer Phil M · CIK 0002012588 · SVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,624

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2020.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:40 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
GrantPerformance Shares · Derivative 60,952 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000070 · wk-form4_1710290395.xml · derivative · entry 16

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,952

Underlying: Common Stock, $0.10 par value · 60,952 shares

Expires 2027-03-10

F13 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2027.

F13 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2027.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:40 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
Exercise / conversionPerformance Shares · Derivative 29,311 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000070 · wk-form4_1710290395.xml · derivative · entry 15

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 29,311 shares

Expires 2024-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return.

F12 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:40 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
GrantMarket Share Units · Derivative 40,635 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000070 · wk-form4_1710290395.xml · derivative · entry 14

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,635

Underlying: Common Stock, $0.10 par value · 40,635 shares

Expires 2028-03-10

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F10 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:40 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
OtherMarket Share Units · Derivative 5,854 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000070 · wk-form4_1710290395.xml · derivative · entry 13

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,565

Underlying: Common Stock, $0.10 par value · 5,854 shares

Expires 2027-03-10

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F11 · shares: Represents the cancellation of one-quarter of market share units granted on March 10, 2023 due to the 80% minimum payout factor not being achieved.

F10 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:40 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
OtherMarket Share Units · Derivative 4,765 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000070 · wk-form4_1710290395.xml · derivative · entry 12

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,532

Underlying: Common Stock, $0.10 par value · 4,765 shares

Expires 2026-03-10

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F9 · shares: Represents the cancellation of one-quarter of market share units granted on March 10, 2022 due to the 80% minimum payout factor not being achieved.

F10 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:40 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
Exercise / conversionMarket Share Units · Derivative 4,885 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000070 · wk-form4_1710290395.xml · derivative · entry 11

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,886

Underlying: Common Stock, $0.10 par value · 4,885 shares

Expires 2025-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:40 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
Exercise / conversionMarket Share Units · Derivative 4,192 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000070 · wk-form4_1710290395.xml · derivative · entry 10

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 4,192 shares

Expires 2024-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2020.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:40 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
Tax withholdingCommon Stock, $0.10 par value 9,774 $53.79 $525,743.46
Disclosure

SEC source: 0000014272-24-000070 · wk-form4_1710290395.xml · nonDerivative · entry 9

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,279

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:40 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
OtherCommon Stock, $0.10 par value 10,203 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000070 · wk-form4_1710290395.xml · nonDerivative · entry 8

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,053

F6 · shares: Adjustment to Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:40 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
Exercise / conversionCommon Stock, $0.10 par value 29,311 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000070 · wk-form4_1710290395.xml · nonDerivative · entry 7

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,256

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: Amount represents distribution of performance shares earned under the 2021-2023 Long-Term Performance Award.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:40 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
Tax withholdingCommon Stock, $0.10 par value 2,068 $53.79 $111,237.72
Disclosure

SEC source: 0000014272-24-000070 · wk-form4_1710290395.xml · nonDerivative · entry 6

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,945

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:40 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
OtherCommon Stock, $0.10 par value 842 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000070 · wk-form4_1710290395.xml · nonDerivative · entry 5

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,013

F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:40 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
Exercise / conversionCommon Stock, $0.10 par value 4,885 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000070 · wk-form4_1710290395.xml · nonDerivative · entry 4

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,855

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2021.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:40 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
Tax withholdingCommon Stock, $0.10 par value 1,807 $53.79 $97,198.53
Disclosure

SEC source: 0000014272-24-000070 · wk-form4_1710290395.xml · nonDerivative · entry 3

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,970

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:40 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
OtherCommon Stock, $0.10 par value 660 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000070 · wk-form4_1710290395.xml · nonDerivative · entry 2

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,777

F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 00:40 UTC
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
Exercise / conversionCommon Stock, $0.10 par value 4,192 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000070 · wk-form4_1710290395.xml · nonDerivative · entry 1

Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,437

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2020.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:11 UTC
Poole Ahn AmandaEVP, Chief Human Resources
GrantPerformance Shares · Derivative 17,096 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000072 · wk-form4_1710292278.xml · derivative · entry 17

Poole Ahn Amanda · CIK 0002005210 · EVP, Chief Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,096

Underlying: Common Stock, $0.10 par value · 17,096 shares

Expires 2027-03-10

F14 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2027.

F14 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2027.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:11 UTC
Poole Ahn AmandaEVP, Chief Human Resources
Exercise / conversionPerformance Shares · Derivative 4,140 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000072 · wk-form4_1710292278.xml · derivative · entry 16

Poole Ahn Amanda · CIK 0002005210 · EVP, Chief Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 4,140 shares

Expires 2024-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F13 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return.

F13 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:11 UTC
Poole Ahn AmandaEVP, Chief Human Resources
GrantMarket Share Units · Derivative 11,397 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000072 · wk-form4_1710292278.xml · derivative · entry 15

Poole Ahn Amanda · CIK 0002005210 · EVP, Chief Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,397

Underlying: Common Stock, $0.10 par value · 11,397 shares

Expires 2028-03-10

F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F11 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:11 UTC
Poole Ahn AmandaEVP, Chief Human Resources
OtherMarket Share Units · Derivative 803 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000072 · wk-form4_1710292278.xml · derivative · entry 14

Poole Ahn Amanda · CIK 0002005210 · EVP, Chief Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,411

Underlying: Common Stock, $0.10 par value · 803 shares

Expires 2027-03-10

F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F12 · shares: Represents the cancellation of one-quarter of market share units granted on March 10, 2023 due to the 80% minimum payout factor not being achieved.

F11 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:11 UTC
Poole Ahn AmandaEVP, Chief Human Resources
OtherMarket Share Units · Derivative 810 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000072 · wk-form4_1710292278.xml · derivative · entry 13

Poole Ahn Amanda · CIK 0002005210 · EVP, Chief Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,621

Underlying: Common Stock, $0.10 par value · 810 shares

Expires 2026-03-10

F9 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%.

F10 · shares: Represents the cancellation of one-quarter of market share units granted on March 10, 2022 due to the 80% minimum payout factor not being achieved.

F11 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:11 UTC
Poole Ahn AmandaEVP, Chief Human Resources
Exercise / conversionMarket Share Units · Derivative 690 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000072 · wk-form4_1710292278.xml · derivative · entry 12

Poole Ahn Amanda · CIK 0002005210 · EVP, Chief Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 690

Underlying: Common Stock, $0.10 par value · 690 shares

Expires 2025-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:11 UTC
Poole Ahn AmandaEVP, Chief Human Resources
Exercise / conversionMarket Share Units · Derivative 628 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000072 · wk-form4_1710292278.xml · derivative · entry 11

Poole Ahn Amanda · CIK 0002005210 · EVP, Chief Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 628 shares

Expires 2024-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2020.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:11 UTC
Poole Ahn AmandaEVP, Chief Human Resources
Tax withholdingCommon Stock, $0.10 par value 976 $53.79 $52,499.04
Disclosure

SEC source: 0000014272-24-000072 · wk-form4_1710292278.xml · nonDerivative · entry 9

Poole Ahn Amanda · CIK 0002005210 · EVP, Chief Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,424

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:11 UTC
Poole Ahn AmandaEVP, Chief Human Resources
OtherCommon Stock, $0.10 par value 1,441 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000072 · wk-form4_1710292278.xml · nonDerivative · entry 8

Poole Ahn Amanda · CIK 0002005210 · EVP, Chief Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,400

F6 · shares: Adjustment to Award based on the performance factor applied in accordance with the terms of the Award and certification of performance results by the Board.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:11 UTC
Poole Ahn AmandaEVP, Chief Human Resources
Exercise / conversionCommon Stock, $0.10 par value 4,140 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000072 · wk-form4_1710292278.xml · nonDerivative · entry 7

Poole Ahn Amanda · CIK 0002005210 · EVP, Chief Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,841

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · shares: Amount represents distribution of performance shares earned under the 2021-2023 Long-Term Performance Award.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:11 UTC
Poole Ahn AmandaEVP, Chief Human Resources
Tax withholdingCommon Stock, $0.10 par value 207 $53.79 $11,134.53
Disclosure

SEC source: 0000014272-24-000072 · wk-form4_1710292278.xml · nonDerivative · entry 6

Poole Ahn Amanda · CIK 0002005210 · EVP, Chief Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 701

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:11 UTC
Poole Ahn AmandaEVP, Chief Human Resources
OtherCommon Stock, $0.10 par value 119 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000072 · wk-form4_1710292278.xml · nonDerivative · entry 5

Poole Ahn Amanda · CIK 0002005210 · EVP, Chief Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 908

F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:11 UTC
Poole Ahn AmandaEVP, Chief Human Resources
Exercise / conversionCommon Stock, $0.10 par value 690 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000072 · wk-form4_1710292278.xml · nonDerivative · entry 4

Poole Ahn Amanda · CIK 0002005210 · EVP, Chief Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,027

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2021.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:11 UTC
Poole Ahn AmandaEVP, Chief Human Resources
Tax withholdingCommon Stock, $0.10 par value 192 $53.79 $10,327.68
Disclosure

SEC source: 0000014272-24-000072 · wk-form4_1710292278.xml · nonDerivative · entry 3

Poole Ahn Amanda · CIK 0002005210 · EVP, Chief Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 337

F3 · shares: Shares withheld for payment of taxes upon vesting of awards.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:11 UTC
Poole Ahn AmandaEVP, Chief Human Resources
OtherCommon Stock, $0.10 par value 99 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000072 · wk-form4_1710292278.xml · nonDerivative · entry 2

Poole Ahn Amanda · CIK 0002005210 · EVP, Chief Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 529

F2 · shares: Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:11 UTC
Poole Ahn AmandaEVP, Chief Human Resources
Exercise / conversionCommon Stock, $0.10 par value 628 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000072 · wk-form4_1710292278.xml · nonDerivative · entry 1

Poole Ahn Amanda · CIK 0002005210 · EVP, Chief Human Resources

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 628

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2020.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:21 UTC
Plenge Robert MEVP, Chief Research Officer
GrantPerformance Shares · Derivative 23,220 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000074 · wk-form4_1710292877.xml · derivative · entry 18

Plenge Robert M · CIK 0001773367 · EVP, Chief Research Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,220

Underlying: Common Stock, $0.10 par value · 23,220 shares

Expires 2027-03-10

F15 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2027.

F15 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2027.

Read SEC document
March 10, 2024 Filed Mar 13, 2024 01:21 UTC
Plenge Robert MEVP, Chief Research Officer
Exercise / conversionPerformance Shares · Derivative 6,985 $0.00 $0.00
Disclosure

SEC source: 0000014272-24-000074 · wk-form4_1710292877.xml · derivative · entry 17

Plenge Robert M · CIK 0001773367 · EVP, Chief Research Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 6,985 shares

Expires 2024-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F14 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return.

F14 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2024, subject to a Total Shareholder Return.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.